|
¡¡¥Ø¥ë¥¹¥±¥¢¤Ë¤ª¤¤¤Æ°Õ»Ö·èÄê¤ò¹Ô¤¦¼Ô¤Ï¡¢¤è¤ê¹âÉʼÁ¤Î²Ê³ØÅªº¬µò¤òµá¤á¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£¤·¤«¤·¤Ê¤¬¤é¡¢ÍøÍѲÄǽ¤Êº¬µò¤Ï¡¢¤·¤Ð¤·¤ÐÉÔŬÀڤǤ¢¤ë¡£¿®Íê¤Ë¤뺬µò¤Ï¡¢¸Â¤é¤ì¤¿»ñ¸»¤ÎÃæ¤Ç³«È¯¤µ¤ì¤¿¤â¤Î¤Ë¤¹¤®¤Ê¤¤¡£²Ê³ØÅªº¬µò¤Ë´ð¤Å¤¯Ãθ«¤Ï¡¢°Õ»Ö·èÄê¤Î¾ì¤Î¸½¼Â¤È¤Î´Ö¤Ç¤ÎÉý¹¤¤¥®¥ã¥Ã¥×¤Ë¤è¤ëÂηÏŪ¤Ê·çÅÀ¤òͤ·¤Æ¤¤¤ë¡£¤³¤Î¤¿¤á¡¢¤³¤¦¤·¤¿ÌäÂê¤ËÂФ·¤Æ¥×¥é¥°¥Þ¥Æ¥£¥Ã¥¯¤¢¤ë¤¤¤Ï¼ÂÍÑŪÎ×¾²¸¦µæ¡ÊPCT¡Ë¤Î¼êË¡¤¬ÍѤ¤¤é¤ì¤ë¤³¤È¤È¤Ê¤Ã¤¿¡£PCT¤Ë¤ª¤¤¤Æ¤Ï¡¢¡Ê£±¡ËÎ×¾²Åª¤Ë´ØÏ¢¤¬¤¢¤ê¤½¤¦¤Ê¹àÌܤˤĤ¤¤Æ²ðÆþ¤ò¹Ô¤¤¡¢¡Ê£²¡Ë´ØÏ¢¤·¤¿ÍÍ¡¹¤Ê·²¤òÂоݤȤ·¡¢¡Ê£³¡Ë¿Íͤʾõ¶·¤«¤éÈ︳¼Ô¤ò½¸¤á¡¢¡Ê£´¡ËÀ®²Ì¤Ë¤Ä¤¤¤Æ¤âÉý¹¤¯¤Þ¤È¤á¤ë¡¢¤È¤¤¤Ã¤¿ÊýË¡¤¬¤È¤é¤ì¤ë¡£PCT¤ËÂФ·¤Æ¤ÏÎ×¾²¸¦µæ¤ÎÂ絬ÌϽлñ¼Ô¤Ç¤¢¤ëNIH¤¢¤ë¤¤¤Ï°åÎÅ´ØÏ¢´ë¶È¤Ï¤ï¤º¤«¤Î»ñ¶â±ç½õ¤·¤«¹Ô¤Ã¤Æ¤ª¤é¤º¡¢»ñ¶â¤Î¶¡µë¤Ï¸Â¤é¤ì¤Æ¤¤¤ë¡£ºÇ¶á¤Ç¤Ï¡¢¤è¤ê¹âÉʼÁ¤Îº¬µò¤¬ÆÀ¤é¤ì¤ë¤³¤È¤«¤é¡¢¥Ø¥ë¥¹¥±¥¢¥·¥¹¥Æ¥à¤«¤é¤Î¶¡µë¤¬¾¯¤·¤º¤ÄÁý²Ã¤·¡¢°ú¤Â³¤¤¤Æ¸øÅª¤¢¤ë¤¤¤Ï»äŪ¤Ê»ñ¶â±ç½õ¤â½ù¡¹¤ËÆÀ¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤Æ¤¤Æ¤¤¤ë¡£¤³¤Î¤è¤¦¤ÊÊѲ½¤¬µ¯¤³¤ë¤³¤È¤Ç¡¢Î×¾²¤¢¤ë¤¤¤Ï·ò¹¯À¯ºö¤Î·èÄê¤Ë¤ª¤¤¤Æ¡¢¼ÂÍÑŪÎ×¾²¸¦µæ¤ò³èÍѤ¹¤ë¤³¤È¤Ë¤Ê¤Ã¤Æ¤¯¤ë¤Î¤Ç¤¢¤ë¡£ ¾¶Ï¿¤Î¤ß¡£ Practical clinical trials¤Ë¤Ä¤¤¤ÆÄ´¤Ù¤¿¡£ Íפ¹¤ë¤Ë¡¢¥¨¥Ó¥Ç¥ó¥¹¤È¤¤¤ï¤ì¤ë¤â¤Î¤Ï¡¢¤´¤¯¸Â¤é¤ì¤¿¾ò·ï¤Ç¤Îº¬µò¤Ê¤Î¤Ç¡¢¤Á¤ç¤Ã¤È¤Ç¤âÁ°Äó¤¬ÊѤï¤ë¤È¡¢Ìò¤ËΩ¤¿¤Ê¤¯¤Ê¤ë¡£¤½¤³¤Ç¡¢Éý¹¤¯¡¢Ä´¤Ù¤Æ¤ª¤³¤¦¡¢¤¿¤À¤·²Ê³ØÅª¤Ë¸úΨŪ¤Ê¥Ç¥¶¥¤¥ó¤ò¤·¤Ã¤«¤êÁȤó¤Ç¡¢¤È¤¤¤¦¤³¤È¤é¤·¤¤¡£ Êó¹ðÃÏ¡§Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore ½Ðŵ¡§Tunis SR¡¤Stryer DB¡¤Clancy CM¡§Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy¡¥JAMA¡§290¡§1624-32¡¤2003 PMID¡§14506122 |
¤½¤Î¾
[ ¥ê¥¹¥È | ¾ÜºÙ ]
Á´1¥Ú¡¼¥¸
[1]
|
µ×¤·¤Ö¤ê¤Îµ»ö ¤³¤Î°å»ÕÉÔ¤Τʤ«¡¢°å»Õ¤Ø¤Î¼êÅö¤Æ¤¬Çѻߤµ¤ì¤ë¤½¤¦¤À¡£ ²Æì¤Ë°å»Õ¤¬Í¾¤Ã¤Æ¤¤¤ë¤È¤Ï¡¢Ê¹¤¤¤¿¤³¤È¤¬¤Ê¤¤¡£¤à¤·¤í¡¢Çɸ¯¤ò¼õ¤±¤Æ¤¤¤¿¤Î¤Ç¤Ï¤Ê¤«¤Ã¤¿¤«¡£ ¹ÔÀ¯¥×¥í¥Ñ¡¼¤ÎÀèÀ¸¤Ï»Ä¤ë¤È»×¤¦¤¬¡¢¹ñ¸øÎ©¤ÎÂè°ìÀþ¤ò¥ê¥¿¥¤¥¢¤·¤Æ¡¢ÊÝ·ò½ê²¿¤«¤Ë¤¤¤ëÀèÀ¸Êý¤Ï¡¢¼¤á¤ë¤«¡¢Â¾¤Î¸©¤Ë°Ü¤ë¤ó¤¸¤ã¤Ê¤«¤í¤¦¤«¡£¸üÀ¸Ï«Æ¯¾Ê¤«¤é¤ÎÇɸ¯¤ÎÀèÀ¸Êý¤Ï¡¢²Æì¤Ë¤Ï¹Ô¤¤¿¤¬¤é¤Ê¤¯¤Ê¤ë¤À¤í¤¦¡£ ¸©Áí̳Éô¡¢°å»Õ¼êÅöÇѻߤòÄ̹ð 5·î11Æü9»þ43ʬÇÛ¿® ΰµå¿·Êó ¡¡¸©Áí̳Éô¤ÏÊÝ·ò½ê¤Ê¤É¤ÇƯ¤¯ÃλöÉô¶É¤Î°å»Õ£³£²¿Í¤òÂоݤˡ¢ÆÃ¼ì¶Ð̳¼êÅö¤Ë°ÌÃÖÉÕ¤±¤é¤ì¤¿°å»Õ¼êÅö¤òÇѻߤ¹¤ëÊý¿Ë¤Ç¤¢¤ë¤³¤È¤¬£±£°Æü¤Þ¤Ç¤Ëʬ¤«¤Ã¤¿¡££±¥«·î¤Î°å»Õ¼êÅö¤Ï¸©Ä£¤ò½ü¤¯ËÜÅçÃæÉô°ÊÆî¤Î¶Ð̳ÃϤǣ´Ëü£µÀé±ß¡¢¸©Ä£¡¦ËÌÉô¤Ç£¹Ëü£µÀé±ß¡¢µÜ¸Å¡¦È¬½Å»³¤Ç£±£¶Ëü±ß¡£¤³¤ì¤ËÂФ·¤ÆÊÝ·ò½ê¤Î°å»Õ¤Ï¡Ö»ÈÌ¿´¶¤ò»ý¤Ã¤ÆÆ¯¤¡¢¥µ¡¼¥Ó¥¹»Ä¶È¤â¿¤¤¡£°å»Õ¤¬Æ¨¤²¤Æ¤·¤Þ¤¦¡£¿Íºà¤Ï½¸¤Þ¤é¤º°å»Õ³ÎÊÝÂкö¤ËµÕ¹Ô¤¹¤ë¡×¤È¤·¤ÆÈ¿È¯¤ò¶¯¤á¤Æ¤¤¤ë¡£¡¡°å»Õ¼êÅö¤¬Çѻߤµ¤ì¤ì¤Ð¡¢¼êÅö¤ò¹â¤¯¤·¤Æ¤¤¤ëÎ¥Åç¤ÎÊÝ·ò½ê¤Ç¤Î°å»Õ³ÎÊݤ¬º¤Æñ¤Ë¤Ê¤ë¤È¤Î·üǰ¤â½Ð¤Æ¤¤¤ë¡£
¡¡Áí̳Éô¤ÏÉôĹ̾¤Ç¡ÖÆÃ¼ì¶Ð̳¼êÅö¸«Ä¾¤·¤Ë·¸¤ëÄ´ºº¤Ë¤Ä¤¤¤Æ¡×¤ÈÂꤷ¤¿¼êÅöÇѻߤÎÊý¿Ë¤òÅÁ¤¨¤ëʸ½ñ¤ò£´·î£²£µÆüÉդǴط¸µ¡´Ø¤ËÁ÷ÉÕ¤·¤¿¡£Ê¸½ñ¤Ç¤Ï¼êÅö¤ÎÇѻߤò¸©¤Î¹ÔºâÀ¯²þ³×¥×¥é¥ó¿ä¿Ê¹àÌܤˤ¢¤ë¡Ö½ô¼êÅö¤ÎÁíÅÀ¸¡¤Î°ì´Ä¡×¤Ç¼Â»Ü¤¹¤ë¤ÈÀâÌÀ¤·¤Æ¤ª¤ê¡¢°Õ¸«¤¬¤¢¤ì¤ÐÊó¹ð¤¹¤ë¤è¤¦µá¤á¤Æ¤¤¤ë¡£¥×¥é¥ó¤Ç¤Ï´Ç¸î»Õ¤äÊÝ·ò»Õ¤é¤Ø¤Î½ô¼êÅö¤ÏÇÑ»ßÂоݤˤʤäƤ¤¤Ê¤¤¡£ ¡¡Íýͳ¤Ë¤Ä¤¤¤ÆÁí̳Éô¤ÎôÅö¼Ô¤Ï¡ÖÆÃ¼ì¶Ð̳¼êÅö¤ÏËÜÍè¡¢´í¸±¤äÉÔ²÷¡¢ÉÔ·ò¹¯¡¢º¤Æñ¤Ê¶Ð̳¤¬ÂоݤÀ¡£°åÎŤϤ³¤ì¤Ë³ºÅö¤·¤Ê¤¤¡£´ðËܵë¤È¤ÎÆó½Å¼è¤ê¤È¤ÎÈãȽ¤¬¤¢¤ë¡£°å»Õ¤Ø¤Î¼êÅö¤Ï¡¢°ìÈÌ¿¦°÷¤è¤ê¹â¤¯»Ùʧ¤ï¤ì¤Æ¤¤¤ëµëÍ¿¤ÇÊä¤ï¤ì¤Æ¤¤¤ë¡×¤ÈÀâÌÀ¤·¤¿¡£¥Ò¥¢¥ê¥ó¥°¤ä¸øÌ³°÷°å»ÕÏ«ÁȤȤÎÃÄÂθò¾Ä¤ò·Ð¤Æ¡¢Áᤱ¤ì¤ÐÍèǯ¤Î£²·î¸©µÄ²ñ¤Ë¼êÅö¾òÎã¤Î²þÀµ°Æ¤òÄó½Ð¤·¤¿¤¤°Õ¸þ¤À¡£ ¡¡ÊÝ·ò½ê¤Î°å»Õ¤Î°ì¿Í¤Ï¡Öʸ½ñ¤ò¸«¤ÆÌܤòµ¿¤Ã¤¿¡£»ÈÌ¿´¶¤ò»ý¤Ã¤ÆÆ¯¤¤¤Æ¤¤¤ë¤¬¡¢¼êÅö¤¬Çѻߤµ¤ì¤ë¤È»Îµ¤¤¬Íî¤Á¤ë¡£¼¤á¤ë°å»Õ¤â½Ð¤ë¤À¤í¤¦¡£¿Íºà³ÎÊݤâ¤Ç¤¤Ê¤¤¡×¤Èȿȯ¡£ ¡¡¡ÖÊÝ·ò½ê¤Ï»ÔĮ¼¤¬¼Â»Ü¤¹¤ë¸¡¿Ç¤Ë»ØÆ³¡¦½õ¸À¤¹¤ë³Ë»ÜÀߤÀ¡£Í½ËɰåÎŤνÅÍ×À¤ÏÁý¤·¤Æ¤ª¤êÌò³ä¤ÏÂ礤¤¡£´¶À÷¾É¤ÎÄ´ºº¤äͽËɤˤâÀºÎϤò¿Ô¤¯¤·¡¢¥µ¡¼¥Ó¥¹»Ä¶È¤Ï·î£µ£°»þ´Ö¤òͤ¨¤ë¡×¤È¼ÂÂÖ¤òÁʤ¨¤¿¡£ ¡Ê¿·³Àµ£¡Ë |
|
¤¢¤ó¤Þ¤ê²Ä°¦¤«¤Ã¤¿¤«¤é¡¢Ìã¤Ã¤ÆÍè¤Á¤ã¤¤¤Þ¤·¤¿¡£ ²Î¤âÂç¹¥¤¤Ê¡¢°æ¾åÍȿ夵¤ó¤Ç¤¹¡£ ¿¿¤óÃæ¤ÎǤÁ¤ã¤ó¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡ª¡ª
|

- >
- Yahoo!¥µ¡¼¥Ó¥¹
- >
- Yahoo!¥Ö¥í¥°
- >
- Îý½¬ÍÑ
Á´1¥Ú¡¼¥¸
[1]


